Beta Thalassemia Intermedia

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 176 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Beta Thalassemia. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Beta Thalassemia (online CE course)
Beta Thalassemia Intermedia

Clinically, beta thalassemia intermedia is midway in severity between major and minor. Growth and development in children with this disorder can usually be considered normal, and most patients have a normal life span; however, some patients have facial bone deformity and/or splenomegaly. Hemoglobin levels are usually decreased with a disproportionately high red blood cell count.
Transfusions (again with iron-chelating agents) may be used as a supportive therapy if necessary.
Beta thalassemia is attributed to a wide variety of genotypes, including B+/B+, B0/B+, or B0/B. All of the genotypes have in common a significant reduction in the production of the beta-globin chain, with a subsequent reduction in the quantity of HbA.